Authors


Herbert D. Kleber, MD

Latest:

The Lasting Effects of Marijuana Use

There is increasing evidence that individuals who try marijuana during their early teenage years are affected neurologically for a decade or more at least until one's 20s and perhaps even longer. More in this video.


Herbert Hendin, MD

Latest:

Commentary: The Case Against Physician-Assisted Suicide: For the Right to End-of-Life Care

Euthanasia is a word coined from Greek in the 17th century to refer to an easy, painless, happy death. In modern times, however, it has come to mean a physician's causing a patient's death by injection of a lethal dose of medication. In physician-assisted suicide, the physician prescribes the lethal dose, knowing the patient intends to end their life.


Herbert Scheier, MD

Latest:

Global Findings in Developmental Psychopathology Presented at ESCAP

A greater understanding of how the brain works, including the effect of environment on it development, has led to advances in diagnosing and treating psychopathology. The latest findings will be presented at an international meeting, along with a discussion of how much work is to be done and the great need for qualified child psychiatrists, especially in developing countries.


Herbert Y. Meltzer, MD

Latest:

Refractory Psychosis: Treatment Options and Strategies

Psychosis is one of the key dimensions of schizophrenia, bipolar disorder, and psychotic depression. Clinicians are familiar with patients whose psychosis improves dramatically with antipsychotic treatment; however, these patients may be left with cognitive impairment, negative mood symptoms, or suicidal symptoms, as well as impaired work and social functioning.


Herman M. Van Praag, MD, PhD

Latest:

Enlightenment and Dimmed Enlightenment

Psychiatrists cannot, with impunity, disregard an important domain of man’s personality makeup. He ought to remain a searcher of the soul at large.


Hilit Kletter, PhD

Latest:

Treatment of Traumatic Stress Disorder in Children and Adolescents

The role of prevention of trauma and prevention of functional impairment after trauma is paramount, because this may disrupt the accumulated physiological and psychological effect of stressors in the individual.


Hind T. Hatoum, PhD

Latest:

Light Treatment for Nonseasonal Depression

Daniel F. Kripke, M.D. has studied the relationship between biological rhythms and depression since the early 1970s. He states that seasonal responses in many mammals are controlled by the photoperiod. Therefore, it seemed that depression might be analogous to winter responses and that light might be an effective treatment.


Hinemoa Elder, MBChB, FRANZCP, PhD

Latest:

Advances in Psychiatry: Understanding Indigenous Cultures

Epidemiological research has shown that the Māori people of New Zealand are approximately twice as likely to have serious psychiatric illness compared with non-Māori. Here, a child and adolescent psychiatrist describes her work in Aotearoa, New Zealand.


Hiroto Ito, PhD

Latest:

Effect of Gender Differences on the Cardiovascular System in Patients With Mental Disorders

Tricyclic antidepressants and antipsychotics are known to prolong cardiac repolarization and induce QTC interval prolongation, possibly putting patients with mental disorders at higher risk of cardiovascular diseases. The mechanism of gender difference in vulnerability for cardiovascular diseases is still unclear, but the role of hormones is one of possible explanatory factors.


Hochang Benjamin Lee, MD

Latest:

Collaborative Care Meets Hospital Medicine: Proactive Consultation-Liaison Psychiatry

Mental illness accounts for a third of all years lived with disability and is associated with twice the relative risk of all-cause mortality. An estimated 8 million deaths are attributable to mental disorders every year, with two-thirds due to comorbid medical illness.


Holly A. Garriock, PhD

Latest:

The μ-Opioid System and Antidepressant Response

This article discusses the role of µ-opioid receptors (MORs) in antidepressant treatment and major depressive disorder (MDD). Specifically, it focuses on how the endogenous opioid system affects response to pharmaceuticals.


Holly Briklin, MD

Latest:

The Adolescent Brain

An expert Q&A with Laurence Steinberg, PhD. His newest book offers insights into the malleable adolescent brain and provides guidance to parents hoping to better understand adolescents.


Holly Peek, MD, MPH

Latest:

Technology in Psychiatry: Year in Review

As technology continues to expand exponentially, so does our potential to harness these technological capabilities to expand the field of psychiatry. At Psychiatric Times this year, we highlighted a range of topics on these advancements.


Howard B. Moss, MD

Latest:

Medical Marijuana and Mental Health: Cannabis Use in Psychiatric Practice

Here's why psychiatrists and other mental health professionals need to understand the relationship between cannabis and mental disorders.


Howard C. Margolese, MD, MSc, FRCPC

Latest:

Introduction: Strategies for Treatment

When thinking about recent advances in psychopharmacology, we often point to new molecules with similar mechanisms of action but with better safety and tolerability profiles, or to molecules with novel mechanisms that effect positive change greater than that with existing treatments.


Howard D. Weiss, MD

Latest:

Management of Psychosis in Parkinson Disease

For some patients with Parkinson disease, the neuropsychiatric complications are a greater source of morbidity than the motor dysfunction. This article focuses on the management of psychosis in Parkinson disease.


Howard Gardner

Latest:

Intelligence Reframed: Multiple Intelligences for the 21st Century

People are different, according to conventional wisdom - the saying generally used in explaining varying opinions, attitudes or ways of thinking. Why then is it not a given that people are different in basic brain functions such as learning and intelligence?


Howard J. Shaffer, PhD

Latest:

Is Computer Addiction a Unique Psychiatric Disorder?

Although it may be tempting to say that almost any rewarding activity can become addicting, new research appears to indicate that, at least in the case of Internet use, that may not be the case. In fact, "Internet addiction" may actually be a sign for other psychiatric disorders.


Howard L. Forman, MD

Latest:

Avoiding the Path of Least Resistance

In this insightful interview, experts discuss the journey toward a more humanistic approach in psychiatry, the challenges of integrating biological and psychosocial aspects, and the need for comprehensive training for future psychiatrists.


Howard S. Rossman, DO

Latest:

Setting Up a Neurology-Based Infusion Center: Rationale and Guidelines

"No longer a pipe dream," is the suggestive lead-in of a widely distributed press release issued last October touting the potential benefits of cannabinoid compounds in the treatment of Parkinson disease (PD), Lou Gehrig disease-or amyotrophic lateral sclerosis (ALS)-and a number of other debilitating conditions, as reported during last fall's 2004 annual meeting of the Society for Neuroscience. According to Daniele Piomelli, PhD, an expert in cannabinoid research and professor in the Department of Pharmacology at the University of California, Irvine, certain cannabinoid compounds can be harnessed to "provide select benefits to patients while avoiding some of the unwanted effects" associated with marijuana use. Compounds of greatest interest have been WIN 55212-2, delta(9)-tetrahydrocannabinol (THC), and anandamide.


Howard Spivak, MD

Latest:

An Early Warning Sign for Violence

Bullying and being bullied put adolescents at risk for developing violent behaviors. Depression and anxiety are two of the underlying issues related to this type of behavior. Recognizing the warning signs may help mental health care professionals prevent violence in the adolescent's life.


Hua Jin, MD

Latest:

Glucose Dysregulation

The atypical antipsychotics have become the treatment of choice for patients with psychotic and other behavioral disorders. However, case reports, retrospective studies and epidemiological data suggest that these medications may be associated with new-onset type 2 diabetes and diabetic ketoacidosis.


Hugh Myrick, MD

Latest:

The Diagnosis and Treatment of Substance Abuse/ Dependence and Co-Occurring Social Anxiety Disorder

Social anxiety disorder and drug addiction commonly co-occur in the same individual, complicating the presentation, course and treatment of both disorders. Using drugs or alcohol may be a coping mechanism for social anxiety; however, many treatments for addiction are group-based approaches, which would be especially challenging for people with social anxiety disorder. This article provides a brief overview of what is known about the co-occurrence of these disorders, as well as possible treatment interventions for this population.


Humberto Marin, MD

Latest:

Unexplained Physical Symptoms

he key manifestations of DSM-IV somatoform disorder are unexplained physical symptoms or complaints that tend to coexist with other psychiatric syndromes or are linked to psychological issues. These symptoms typically lead to repeated medical or emergency department visits; are associated with serious discomfort, dysfunction, and disability; and lead to significant health expenditures.


Hunter L. McQuistion, MD

Latest:

Outside the Pill Box: The Systems-Based Practice of Psychiatry

Meet "Gary," whose case provides an introduction to the value of systems-based practice.


Hussam Jefee-Bahloul, MD

Latest:

Pharmacogenetics to Predict Treatment Outcome in Substance Use Disorders

This brief communication highlights the importance of genetic predictors and moderators of treatment research in the field of substance use.


Husseini K. Manji, MD

Latest:

Digital Health as an Enabler for Patient-Centric, Outcome-Based Care

Considering challenges and opportunities in digital health solutions for mental health care.


Hy Bloom, MD

Latest:

Managing the Aftermath of Patient-on-Staff Violence

Violence by patients towards staff members is an inherently complex matter for the physically and/or psychologically injured person. An expert in the field of forensic psychiatry answers a reader's question about what clinicians can do in the aftermath of an assault.


Ian Alger, MD

Latest:

Creative Media in Psychotherapy

Nonverbal cues speak just as loudly as words. How can video be used to capture these subtle cues and help patients make progress in therapy?


Icelini Garcia-sosa, MD

Latest:

Reasons Patients Doubt Medication-Resistant Delusions in Schizophrenia

Our study suggests that most delusional patients, even those with high positive symptom scores, may have at least 1 RFD that precedes a clinical intervention specifically directed toward encouraging doubt. These preexisting “islands of doubt” may offer a useful foothold to begin the CBT process.

© 2025 MJH Life Sciences

All rights reserved.